Clinical Trial Update: Effect of Homocysteine-lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated whether lowering homocysteine with folic acid, vitamin B12, and vitamin B6 improves endothelium-dependent vasodilatation in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Endothelial Dysfunction

Drugs mentioned

• Vitamin B12 (cobalamin)
• Vitamin B6 (pyridoxine)
• folic acid (folic acid)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Cardiovascular Disease, Endothelial Dysfunction | Phase 2 | Status: COMPLETED